Skip to main content

Table 4 Ovarian cancer with brain metastases – survival by treatment modality after diagnosis of brain metastases [32]

From: Surgical management of lung, liver and brain metastases from gynecological cancers: a literature review

Treatment modality Median survival (months) % of patients (n)
Total = 538
WBRT* only 4.5 35 % (182)
Surgery + WBRT 17 15.2 % (79)
WBRT + chemo 9.1 13.5 % (70)
Surgery + WBRT + chemo 20 13.3 % (69)
Surgery only 6.7 5 % (26)
SRS* or GKRS* 18 3.8 % (20)
Chemo only 7.5 1.9 % (10)
Surgery + chemo Not available 1.3 % (7)
No treatment (steroids only) 1.4 11 % (57)
  1. *WBRT whole brain radiationtherapy, SRS stereotactic radiosurgery, GKRS gamma knife radiosurgery